The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

December 2019

Volume 15 Number 12

This issue looks at MR severity as a predictor of therapeutic benefit in TMVI using the Tendyne system; the impact of elevated tricuspid valve inflow gradients after TTVR; TAVI vs SAVR in low surgical risk patients; the ANGIOLITE trial, a first-in-man comparison of the Angiolite SES with an EES in CAD; and an examination of stent thrombosis after endovascular revascularisation of the superficial femoral artery.

Highlights from this issue

Coronary
The ANGIOLITE trial
The ANGIOLITE trial
Moreu J, Moreno-Gómez R, Perez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I
December 20, 2019
DOI: 10.4244/EIJ-D-19-00206

Interventions for valvular disease and heart failure

Clinical research
Meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low surgical risk
Witberg G, Landes U, Lador A, Yahav D, Kornowski R
December 20, 2019 | 10.4244/EIJ-D-19-00663
Clinical research
Clinical impact of elevated tricuspid valve inflow gradients after transcatheter edge-to-edge tricuspid valve repair
Orban M, Orban M, Braun D, Deseive S, Kupka D, Stocker T, Bagaev E, Karam N, Hagl C, Massberg S, Nabauer M, Hausleiter J
December 20, 2019 | 10.4244/EIJ-D-19-00237
Clinical research
Mitral regurgitation severity predicts one-year therapeutic benefit of Tendyne transcatheter mitral valve implantation
Badhwar V, Sorajja P, Duncan A, Thourani V, Schaefer U, Grayburn P, Dumonteil N, Babaliaros V, Garatti A, Lessick J, Chuang M, Blanke P, Muller D
December 20, 2019 | 10.4244/EIJ-D-19-00333
Will this trial change my practice ?
Will the Evolut Low Risk trial change my practice?
O'Sullivan C, Reardon M, Søndergaard L, Treede H, Jüni P, Windecker S
December 20, 2019 | 10.4244/EIJ-D-19-00587
Will this trial change my practice ?
Will the PARTNER 3 Low Risk Trial change my practice?
McConkey H, Modine T, Latib A, Jüni P, Windecker S, Leon M
December 20, 2019 | 10.4244/EIJ-D-19-00847

Coronary interventions

Clinical research
First-in-man randomised comparison of the Angiolite durable fluoroacrylate polymer-based sirolimus-eluting stent versus a durable fluoropolymer-based everolimus-eluting stent in patients with coronary artery disease: the ANGIOLITE trial
Moreu J, Moreno-Gómez R, Perez de Prado A, García del Blanco B, Trillo R, Pinar E, Molina E, Zueco J, Merchán A, Díaz-Fernández J, Amat I
December 20, 2019 | 10.4244/EIJ-D-19-00206
Clinical research
Patient-oriented composite endpoints and net adverse clinical events with ticagrelor monotherapy following percutaneous coronary intervention: insights from the randomised GLOBAL LEADERS trial
Serruys P, Tomaniak M, Chichareon P, Modolo R, Kogame N, Takahashi K, Chang C, Spitzer E, Walsh S, Adlam D, Hildick-Smith D, Édes I, van de Harst P, Krackhardt F, Tijssen J, Rademaker-Havinga T, Garg S, Steg P, Hamm C, Jüni P, Vranckx P, Onuma Y, Verheugt F
December 20, 2019 | 10.4244/EIJ-D-19-00202
Clinical research
Effect of rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: the LINK-IT Trial
Kuroda K, Otake H, Shinohara M, Kuroda M, Tsuda S, Toba T, Nagano Y, Toh R, Ishida T, Shinke T, Hirata K
December 20, 2019 | 10.4244/EIJ-D-18-01073
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke